CD123: A Novel Biomarker for Diagnosis and Treatment of Leukemia.

导出原文传递

翻译打印收藏纠错

作者： Mingyue,Shi ^[1] ; Ruijun J,Su ^[2] ; Kamal-Preet,Parmar ^[3] ; Rahman,Chaudhry ^[1] ; Kai,Sun ^[1] ; Jianyu,Rao ^[2] ; Mingyi,Chen ^[3]

作者单位： Department of Pathology and Laboratory Medicine, UT Southwestern Medical Center, Dallas, TX 75390, United States. ^[1] Department of Hematology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Henan, China. ^[2] Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Ronald Reagan UCLA Medical Center, Los Angeles, CA 90095, United States. ^[3]

关键词 CD123 LSCs anti-CD123 hematologic malignant diseases leukemia refractory/relapse.

主题词动物(Animals);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);白细胞介素3受体α亚单位(Interleukin-3 Receptor alpha Subunit);白血病(Leukemia)

DOI 10.2174/1871529X19666190627100613

PMID 31244444

发布时间 2020-08-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交